The Immune Landscape of Cancer
2018 · Immunity · 6,071 citations
https://doi.org/10.1016/j.immuni.2018.03.023
M
Mary L. Disis
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
657
Papers
32.5K
Citations
76
h-index
225
i10-index
Mary L. Disis is an academic researcher from University of Washington. The author has contributed to research in topics: Immunotherapy and Immune Responses & Cancer Immunotherapy and Biomarkers & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 76, co-authored 559 publications.
ORCID: 0000-0001-7653-4648Papers by this author
worksTumor antigen-specific T helper cells in cancer immunity and immunotherapy
2005 · Cancer Immunology Immunotherapy · 673 citations
https://doi.org/10.1007/s00262-004-0653-2
Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes
2016 · JAMA Oncology · 627 citations
https://doi.org/10.1001/jamaoncol.2016.1061
Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer.
1994 · PubMed · 467 citations
Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients
2001 · Journal of Clinical Investigation · 450 citations
https://doi.org/10.1172/jci11752
Generation of T-Cell Immunity to the HER-2/neu Protein After Active Immunization With HER-2/neu Peptide–Based Vaccines
2002 · Journal of Clinical Oncology · 425 citations
https://doi.org/10.1200/jco.2002.06.171
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat